Document ID: chunk:federal_register_of_legislation:F2024L01045:reg:9:p1
Version: federal_register_of_legislation:F2024L01045
Segment Type: reg
Provision Reference: reg 9 (pt 1/3)
Character Range: 4199–7446

9               Factors that must exist
At least one of the following factors must as a minimum exist before it can be said that a reasonable hypothesis has been raised connecting osteoporosis or death from osteoporosis with the circumstances of a person's relevant service:
(1)          being a prisoner of war before clinical onset or clinical worsening;
(2)          having one of the following autoimmune diseases for at least the 1 year before clinical onset or clinical worsening;
(a)          ankylosing spondylitis;
(b)          dermatomyositis;
(c)          psoriatic arthritis;
(d)          rheumatoid arthritis;
(e)          systemic lupus erythematosus; or
(f)           systemic sclerosis;
(3)          having human immunodeficiency virus infection for at least the 1 year before clinical onset or clinical worsening;
(4)           having multiple sclerosis or Parkinson disease for at least the one year before clinical onset or clinical worsening;
(5)          having chronic renal impairment with a glomerular filtration rate of <45 ml/min/1.73 m2 for at least 3 months before clinical onset or clinical worsening;
(6)          having myeloma, non-Hodgkin lymphoma, Hodgkin lymphoma or systemic mastocytosis at the time of clinical onset or clinical worsening;
Note: systemic mastocytosis is defined in the Schedule 1 – Dictionary.
(7)          having a solid organ (excluding corneal transplant), stem cell or bone marrow transplantation before clinical onset or clinical worsening;
(8)          having one of the following endocrine abnormalities for a continuous period of at least 1 year within the 10 years before clinical onset or clinical worsening;
(a)          Cushing syndrome;
(b)          Graves disease;
(c)          hyperprolactinaemia;
(d)          hyperthyroidism or thyrotoxicosis;
(e)          hypogonadism (including menopause);
(f)           primary hyperparathyroidism; or
(g)          type 1 diabetes mellitus;
(9)          having one of the following gastrointestinal diseases at the time of clinical onset or clinical worsening;
(a)          chronic exocrine pancreatic insufficiency;
(b)          cirrhosis of the liver;
(c)          coeliac disease; or
(d)          inflammatory bowel disease.
(10)      having total or partial gastrectomy or a Roux-en-Y gastric bypass at least 1 year before clinical onset or clinical worsening;
(11)      for a minimal trauma fracture only, being pregnant within the 6 months before clinical onset;
(12)      having anorexia nervosa before clinical onset or clinical worsening;
Note: anorexia nervosa is defined in the Schedule 1 – Dictionary.

(13)      taking one of the following glucocorticoids orally, intravenously or intramuscularly before clinical onset or clinical worsening:
(a)          betamethasone to a cumulative quantity of at least 60 mg within 6 months, or a cumulative quantity of at least 360 mg over any duration;
(b)          cortisone to a cumulative quantity of at least 2,500 mg within 6 months, or a cumulative quantity of at least 15,000 mg over any duration;
(c)          dexamethasone to a cumulative quantity of at least 75 mg within 6 months, or a cumulative quantity of at least 450 mg over any duration;
(d)          hydrocortisone to a